Selegiline for better sex

By Serge Kreutz

The agenda is better sex. It’s that clear and simple. Actually, most things in life are subordinate to better sex. This is the case because, in a very essential way, we, as humans, and probably more as males than as females, derive philosophical meaning for our existence primarily from sexual satisfaction. If sexual satisfaction is no longer available, we are vegetating rather than living.

I do not know of any textbook of sexual enhancement. There are textbooks on crutches. On hairdos. Or on chemistry. Why is there none on sexual chemistry? The term isn’t even taken literally by most people. And sexual enhancement, so far, is not a discipline that is thought in medical school or psychology programs.

Sexual chemistry (which is less than sexual enhancement) is covered here and there in medical textbooks. But the coverage is by far not consistent, and the topic is treated rather in footnotes.

For philosophical reasons, I consider sexual enhancement as one of the most important themes in male studies. And it’s worthy a dedicated textbook.

I am a scientific researcher, not a MD. I have a background in biology, but as far as sexual enhancement goes, I have a background primarily as having been my own test subject. I am sure that I know more on sexual enhancement than your urologist (who, I am sure, knows more on making a quick buck).

Selegiline is a selective monoamine oxidase (MAO) B inhibitor, used for many years in the treatment of Parkinson’s Disease. Parkinson’s Disease is a well-defined ailment characterized by the depletion of the neurotransmitter dopamine. Deprenyl, or L-deprenyl, is an alternative generic name for selegiline hydrochloride. The most common brand names are Eldepryl and Jumex.

However, we take interest not so much in the use of selegiline as a treatment for Parkinson’s Disease but in the potential, selegiline has as a lifestyle drug. Selegiline’s potential as lifestyle drug lies primarily in its sexuality-enhancing power.